Patent details

EP3325013 Title: STIMULATORS / ACTIVATORS OF SOLUBLE GUANYLAT CYCLASE IN COMBINATION WITH A NEP-INHIBITOR AND AN ANGIOTENSIN AII-ANTAGONIST AND THE USE THEREOF

Basic Information

Publication number:
EP3325013
PCT Application Number:
EP2016066891
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP167391465
PCT Publication Number:
WO2017013010
First applicant's nationality:
Translation Language:
EPO Publication Language:
German
English Title of Invention:
STIMULATORS / ACTIVATORS OF SOLUBLE GUANYLAT CYCLASE IN COMBINATION WITH A NEP-INHIBITOR AND AN ANGIOTENSIN AII-ANTAGONIST AND THE USE THEREOF
French Title of Invention:
STIMULATEURS / ACTIVATEURS DE GUANYLATE CYCLASE SOLUBLE EN COMBINAISON AVEC UN INHIBITEUR DE L'ENDOPEPTIDASE NEUTRALE (NEP) ET UN ANTAGONIST D'ANGIOTENSIN II ET SON UTILISATION
German Title of Invention:
STIMULATOREN UND/ODER AKTIVATOREN DER LÖSLICHEN GUANYLATZYKLASE (SGC) IN KOMBINATION MIT EINEM INHIBITOR DER NEUTRALEN ENDOPEPTIDASE (NEP INHIBITOR) UND EINEM ANGIOTENSIN AII-ANTAGONISTEN UND IHRE VERWENDUNG
SPC Number:

Dates

Filing date:
15/07/2016
Grant date:
23/09/2020
EP Publication Date:
30/05/2018
PCT Publication Date:
26/01/2017
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
23/09/2020
EP B1 Publication Date:
23/09/2020
EP B2 Publication Date:
19/07/2023
EP B3 Publication Date:
Lapsed date:
Expiration date:
15/07/2036
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
12/07/2023
 
 

Name:
Bayer Pharma Aktiengesellschaft
Address:
Müllerstrasse 178, 13353 Berlin, Germany (DE)

Agent

Name:
ARONOVA S.A.
From:
02/12/2020
Address:
PO Box 327, L-4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
To:

Inventor

1

Name:
STASCH, Johannes-Peter
Address:
Italy (IT)

2

Name:
FOLLMANN, Markus
Address:
Germany (DE)

3

Name:
MARQUARDT, Tobias
Address:
Germany (DE)

Priority

Priority Number:
15178141
Priority Date:
23/07/2015
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC classification:
A61K 45/06; A61K 31/216; A61K 31/41; A61K 31/506; A61K 31/519; A61P 9/00; A61P 3/14; A61P 7/02; A61P 7/10; A61P 9/04; A61P 11/00; A61P 13/12; A61P 43/00; A61P 3/06;

Publication

European Patent Bulletin

1

Issue number:
202039
Publication date:
23/09/2020
Description:
Grant (B1)

2

Issue number:
202129
Publication date:
21/07/2021
Description:
Opposition procedure started

3

Issue number:
202329
Publication date:
19/07/2023
Description:
Patent maintained (B2 publication)

4

Issue number:
202321
Publication date:
24/05/2023
Description:
Title of invention Modified

Annual Fees

Annual Fee Due Date:
31/07/2026
Annual Fee Number:
11
Annual Fee Amount:
148 Euro
Expected Payer:
Last Annual Fee Payment Date:
25/06/2025
Last Annual Fee Paid Number:
10
Last Annual Fee Paid Amount:
131 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
02/12/2020 Power Of Attorney 1
02/12/2020 Outgoing Correspondence 1